Market News

Pharma in her DNA, Wockhardt scion ready for deep dive in the US

Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades without new antibiotics. Zahabiya is focused on hospital penetration, physician advocacy, and demonstrating economic value to healthcare systems.

PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Sebi may widen 50% overlap rule to thematic passive mutual fund schemes

Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers

A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.

Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Here is the one sector bucking the trend in a weak market; Check out top gainers

Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).

Bharti Airtel Share Price Live Updates: Bharti Airtel's Beta Value Explained

Hindalco Share Price Live Updates: Hindalco's beta value points to increased volatility

Britannia Share Price Live Updates: Britannia's beta value highlights market stability

Rubicon Research jumps 15% to hit 52-week high on Q4 results, dividend news

Along with its quarterly results, the board recommended a dividend of ₹1.50 per equity share of face value ₹1 each, fully paid up, for the financial year ended March 31, 2026

Medtech exporter Poly Medicure bets on high-tech pivot and acquisitions to fend off macro headwinds

The medtech major expects its growth rate to more than double in FY27 as it pivots from low-cost consumables to high-value equipment to counter Chinese competition and rising input costs.

Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms

The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.